#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11056	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2192	497.6	0	.	n	.	0	C451T	SNP	451	451	C	662	662	T	620	T,C	600,6	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11056	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2192	497.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1395	1395	C	642	C	630	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19736	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3550	552.3	0	.	n	.	0	T695C	SNP	695	695	T	1029	1029	C	623	C,G	604,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19736	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3550	552.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2305	2305	C	613	C,T,G	589,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19736	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3550	552.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2379	2379	A	626	A	607	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19736	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3550	552.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2931	2931	C	613	C	600	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19736	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3550	552.3	0	HET	.	.	.	A1638G	.	1638	1638	A	1972	1972	A	605	A,G	428,159	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	112	blaTEM	861	861	100.0	blaTEM.l6.c30.ctg.1	1070	9.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1498	folP	855	855	100.0	folP.l15.c4.ctg.1	1579	94.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1100	1102	AGC	144;142;143	A;G;C	140;135;137	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4732	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3374	139.2	1	SNP	p	S91F	1	.	.	271	273	TTC	544	546	TTC	155;158;164	T;T;C	155;155;161	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4732	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3374	139.2	1	SNP	p	G95N	0	.	.	283	285	GGC	556	558	GGC	159;159;157	G;G,A;C	155;153,2;156	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4732	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3374	139.2	1	SNP	p	D95G	1	.	.	283	285	GGC	556	558	GGC	159;159;157	G;G,A;C	155;153,2;156	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1186	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1371	85.8	1	SNP	p	G45D	0	.	.	133	135	GGC	481	483	GGC	146;144;141	G;G,A;C	142;141,1;139	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	594	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	993	59.2	0	.	n	.	0	A197.	DEL	197	197	A	567	567	A	130	A	126	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3632	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2837	127.0	1	SNP	p	D86N	0	.	.	256	258	GAC	485	487	GAC	157;157;157	G;A,C;C	155;146,1;157	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3632	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2837	127.0	1	SNP	p	R87I	0	.	.	259	261	CGT	488	490	CGT	161;164;166	C;G;T	160;163;160	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3632	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2837	127.0	1	SNP	p	S87R	1	.	.	259	261	CGT	488	490	CGT	161;164;166	C;G;T	160;163;160	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3632	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2837	127.0	1	SNP	p	R87W	0	.	.	259	261	CGT	488	490	CGT	161;164;166	C;G;T	160;163;160	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3632	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2837	127.0	1	SNP	p	S88P	0	.	.	262	264	TCC	491	493	TCC	167;165;166	T;C;C,T	164;163;160,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3272	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2675	121.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1537	1539	GGC	136;135;139	G;G;C	135;133;138	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.35.001	penA.35.001	1	1	27	2700	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2450	109.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1302	1304	GCC	143;145;147	G;C;C	138;140;143	penA.35.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2700	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2450	109.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1305	1307	ATG	149;149;149	A,G;T;G	145,1;145;146	penA.35.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2700	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2450	109.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1317	1319	ACC	144;146;149	A;C;C	138;141;145	penA.35.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2700	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2450	109.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1317	1319	ACC	144;146;149	A;C;C	138;141;145	penA.35.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2700	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2450	109.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1818	1820	ACC	134;133;134	A;C;C	130;130;130	penA.35.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2700	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2450	109.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1872	1874	GCG	133;130;129	G;C;G,C,T	124;111;121,1,1	penA.35.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2700	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2450	109.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1872	1874	GCG	133;130;129	G;C;G,C,T	124;111;121,1,1	penA.35.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2700	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2450	109.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1995	1997	GGT	107;105;102	G;G;T	106;102;97	penA.35.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2700	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2450	109.1	1	SNP	p	G545S	0	.	.	1633	1635	GGC	2004	2006	GGC	94;92;92	G;G;C	91;89;89	penA.35.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2700	penA	1746	1746	100.0	penA.l6.c30.ctg.1	2450	109.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2022	2024	CCG	65;66;65	C;C;G,C	62;64;55,1	penA.35.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4164	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3008	137.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1556	1558	CCG	147;145;146	C;C;G	136;139;139	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1764	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1803	96.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	572	572	C	109	C	103	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1912	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1639	115.6	0	.	p	.	0	I45V	NONSYN	133	135	ATT	420	422	GTT	146;145;146	G;T;T	142;140;144	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1912	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1639	115.6	0	.	p	.	0	G48A	NONSYN	142	144	GGA	429	431	GCA	143;145;148	G;C,G;A	141;141,1;145	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1912	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1639	115.6	1	SNP	p	G120K	1	.	.	358	360	AAG	645	647	AAG	159;159;158	A,G,C;A,G;G,T,A	144,3,1;151,3;140,3,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1912	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1639	115.6	1	SNP	p	A121N	1	.	.	361	363	AAC	648	650	AAC	160;157;154	A,G;A,C;C,A	150,3;147,3;141,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	1912	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1639	115.6	1	SNP	p	N121D	0	.	.	361	363	AAC	648	650	AAC	160;157;154	A,G;A,C;C,A	150,3;147,3;141,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6532	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4859	133.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	790	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1077	73.2	1	SNP	p	V57M	1	.	.	169	171	ATG	525	527	ATG	150;150;150	A;T;G	148;146;143	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	16	26	tetM	1920	602	100.0	tetM.l6.c30.ctg.1	602	1.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
